6833 — Sinco Pharmaceuticals Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Sinco Pharmaceuticals Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	144	326	329	438	308
Net Total Accounts Receivable
Net Total Receivables	588	225	390	593	681
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,006	969	1,017	1,433	1,512
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	238	256	316	354	371
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,252	1,233	1,424	1,891	2,000
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	991	726	791	1,232	1,332
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	1,087	858	821	1,263	1,338
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	165	375	604	628	663
Total Liabilities & Shareholders' Equity	1,252	1,233	1,424	1,891	2,000
Total Common Shares Outstanding